Erbb2 rat/human hybrid vaccine eludes self-antigen tolerance and elicits an effective t cells response in erbb2 cancer patients

Authors
Publication date
1 January 2012
Publisher
FOCIS

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Institutional Research Information System University of Turin

    redirect
    oaioai:iris.unito.it:2318/125872
    Last time updated on 02/03/2023